GURUFOCUS.COM » STOCK LIST » USA » NYSE » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Quick Ratio
Switch to:

Nuvation Bio Quick Ratio

: 33.57 (As of Jun. 2022)
View and export this data going back to 2021. Start your Free Trial

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Nuvation Bio's quick ratio for the quarter that ended in Jun. 2022 was 33.57.

Nuvation Bio has a quick ratio of 33.57. It generally indicates good short-term financial strength.

The historical rank and industry rank for Nuvation Bio's Quick Ratio or its related term are showing as below:

NUVB.WS' s Quick Ratio Range Over the Past 10 Years
Min: 33.69   Med: 52.74   Max: 83.19
Current: 34.89

During the past 2 years, Nuvation Bio's highest Quick Ratio was 83.19. The lowest was 33.69. And the median was 52.74.

NUVB.WS's Quick Ratio is ranked better than
96.09% of 1559 companies
in the Biotechnology industry
Industry Median: 5.23 vs NUVB.WS: 34.89

Nuvation Bio Quick Ratio Historical Data

The historical data trend for Nuvation Bio's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Annual Data
Trend Dec20 Dec21
Quick Ratio
33.69 45.62

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Quick Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.58 59.86 45.62 34.89 33.57

Competitive Comparison

For the Biotechnology subindustry, Nuvation Bio's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Nuvation Bio Quick Ratio Distribution

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Quick Ratio falls into.



Nuvation Bio Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Nuvation Bio's Quick Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Quick Ratio (A: Dec. 2021 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(772.073-0)/16.925
=45.62

Nuvation Bio's Quick Ratio for the quarter that ended in Jun. 2022 is calculated as

Quick Ratio (Q: Jun. 2022 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(714.264-0)/21.274
=33.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB.WS) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Nuvation Bio Quick Ratio Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio Business Description

Nuvation Bio logo
Traded in Other Exchanges
Address
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)